Voice of America
‘Zombie Cells’: Researchers Fight Aging Process of the Human Body
Creatures that refuse to die, commonly known as zombies, have appeared in popular movies and television shows for years.
Recent research has shown that an unusual part of real human biology possesses zombie-like qualities: a special kind of cells.
Like the stars of many scary stories, these so-called ‘zombie cells’ also refuse to die. Studies suggest that, as they build up in your body, they lead to aging and the conditions that come with that process, like bone and brain diseases.
Now, researchers are studying drugs that can kill zombie cells and possibly treat the problems they bring.
James Kirkland is a medical doctor and aging specialist with the Mayo Clinic in Rochester, Minnesota. He is working on the research. He told the Associated Press that, generally, the goal is to fight aging itself. This in turn may delay the appearance of some age-related disease and disabilities.
The research has been done mainly in mice. Earlier this year, the first test on people was published and provided some interesting results.
Zombie cells are actually called senescent cells. They start out like usual cells, but then face problems, like viral infection or damage to their genetic material (DNA). At that point, a cell may die or become a zombie cell – entering a state of suspended animation.
These zombie cells release chemicals that can harm nearby normal cells. That is where the trouble starts.
What kind of trouble In studies on mice, drugs that destroy zombie cells — called senolytics — have been shown to improve many different conditions. This includes cataracts, diabetes, enlargement of the heart, kidney problems, and age-related muscle loss.
Mouse studies have also shown a more direct tie between zombie cells and aging. When drugs targeting those cells were given to older mice, the animals showed improved walking speed, strength and an ability to continue physical activity. Even when researchers used the treatment on very old mice, it extended their lifespan by about 36 percent.
Researchers have also shown that putting zombie cells into young mice generally made them act older. Their walking speed slowed down. Their muscle strength and ability to stay active also decreased. Tests showed the newly added cells changed other cells into the zombie state.
This year, Kirkland and his team published the first study of a zombie-cell treatment in people. It involved 14 patients with idiopathic pulmonary fibrosis, an often deadly lung disease. Risk of the disease rises with age, and patients’ lungs show evidence of zombie cells.
After three weeks of treatment, patients who took part in the experiment improved on some measures of physical health, like walking speed. Other measures did not show improvement.
Gregory Cosgrove is a doctor and chief medical officer of the Pulmonary Fibrosis Foundation. He was not involved in the study. He noted that, overall, the results are a good sign.
“It really raises enthusiasm to proceed with the more rigorous studies,” Cosgrove said.
The field of zombie cell research is still young. But Kirkland estimates at least 12 companies have formed or launched efforts to study treatments.
Laura Niedernhofer is a professor of biochemistry at the University of Minnesota in Minneapolis. She suggested that, in addition to age-related diseases, anti-zombie cell drugs might be useful for treating early aging among cancer survivors. This condition brings on the early appearance of some diseases.
Niedernhofer said the goal is not to prevent damaged cells from turning into zombies, because they may become cancerous instead. The aim is to kill cells that have already changed, or to limit the harm they do.
And what about giving them to healthy people who want to prevent aging That is possible bu[...]